TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium.

[1]  Paul K Crane,et al.  Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. , 2012, Archives of neurology.

[2]  J. Nierenberg,et al.  Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants , 2012, Psychoneuroendocrinology.

[3]  K. Roeder,et al.  TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease , 2011, Neurobiology of Aging.

[4]  L. Bekris,et al.  Functional Analysis of APOE Locus Genetic Variation Implicates Regional Enhancers in the Regulation of Both TOMM40 and APOE , 2011, Journal of Human Genetics.

[5]  David M Holtzman,et al.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.

[6]  Dennis Gessmann,et al.  Functional Refolding and Characterization of Two Tom40 Isoforms from Human Mitochondria , 2011, The Journal of Membrane Biology.

[7]  K. Blennow,et al.  TOMM40 poly-T Variants and Cerebrospinal Fluid Amyloid Beta Levels in the Elderly , 2011, Neurochemical Research.

[8]  A. Roses.  An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. , 2010, Archives of neurology.

[9]  A. Roses,et al.  Genetic variation at a single locus and age of onset for Alzheimer's disease , 2010, Alzheimer's & Dementia.

[10]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[11]  P. Moreira,et al.  Alzheimer's disease: a lesson from mitochondrial dysfunction. , 2007, Antioxidants & redox signaling.

[12]  Ellen M Wijsman,et al.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. , 2007, Genomics.

[13]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[14]  D. Stojanovski,et al.  Dissection of the Mitochondrial Import and Assembly Pathway for Human Tom40* , 2005, Journal of Biological Chemistry.

[15]  J. Hardy,et al.  Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. , 1997, Human molecular genetics.

[16]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[17]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[19]  G. Schellenberg,et al.  Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. , 1987, Journal of neurogenetics.